Literature DB >> 15307694

[Clinical observation on treatment of diabetic nephropathy with compound fructus arctii mixture].

Hai-ying Wang1, Yi-ping Chen.   

Abstract

OBJECTIVE: To observe the effect of Compound Fructus Arctii Mixture (FAM, consisted of Fructus Arctii and ethanol extract of Radix Astragalus membranaceus) in treating diabetic nephropathy.
METHODS: Using FAM to treat 31 patients with diabetic nephropathy and controlled by 23 patients treated with Losartan, the therapeutic course was 3 months for both groups, changes of clinical symptoms, blood glucose, lipid metabolism and urinary albumin were observed and compared.
RESULTS: The total effective rate in the treated group was 80.6% while in the control group 65.2%. The symptoms, urinary protein and albumin as well as lipid metabolism in the treated group all significantly improved after treatment (P<0.05), but in the control group improvement only showed in urinary albumin level (P<0.05).
CONCLUSION: FAM has the effects of reducing urinary protein in 24 hrs, lowering urinary albumin, improving blood glucose after meal and lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15307694

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  Effect of Qufengtongluo Decoction on PI3K/Akt Signaling Pathway in the Kidney of Type 2 Diabetes Mellitus Rat (GK Rat) with Diabetic Nephropathy.

Authors:  Wei-Jun Huang; Qiang Fu; Yong-Hua Xiao; Qing Gong; Wen-Jing Wu; Zi-Long Shen; Hua Zhang; Xu Jia; Xue-Min Huang; Ya-Xin Zhang; Jin-Xi Zhao; Shi-Dong Wang; Mian Jia; Yu-Ting Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-14       Impact factor: 2.629

2.  Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes.

Authors:  Yifei Zhong; Kyung Lee; Yueyi Deng; Yueming Ma; Yiping Chen; Xueling Li; Chengguo Wei; Shumin Yang; Tianming Wang; Nicholas J Wong; Alecia N Muwonge; Evren U Azeloglu; Weijia Zhang; Bhaskar Das; John Cijiang He; Ruijie Liu
Journal:  Nat Commun       Date:  2019-10-04       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.